» Articles » PMID: 12477719

Cooperation of Gq, Gi, and G12/13 in Protein Kinase D Activation and Phosphorylation Induced by Lysophosphatidic Acid

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Dec 13
PMID 12477719
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

To examine the contribution of different G-protein pathways to lysophosphatidic acid (LPA)-induced protein kinase D (PKD) activation, we tested the effect of LPA on PKD activity in murine embryonic cell lines deficient in Galpha(q/11) (Galpha(q/11) KO cells) or Galpha(12/13) (Galpha(12/13) KO cells) and used cells lacking rhodopsin kinase (RK cells) as a control. In RK and Galpha(12/13) KO cells, LPA induced PKD activation through a phospholipase C/protein kinase C pathway in a concentration-dependent fashion with maximal stimulation (6-fold for RK cells and 4-fold for Galpha(12/13) KO cells in autophosphorylation activity) achieved at 3 microm. In contrast, LPA did not induce any significant increase in PKD activity in Galpha(q/11) KO cells. However, LPA induced a significantly increased PKD activity when Galpha(q/11) KO cells were transfected with Galpha(q). LPA-induced PKD activation was modestly attenuated by prior exposure of RK cells to pertussis toxin (PTx) but abolished by the combination treatments of PTx and Clostridium difficile toxin B. Surprisingly, PTx alone strikingly inhibited LPA-induced PKD activation in a concentration-dependent fashion in Galpha(12/13) KO cells. Similar results were obtained when activation loop phosphorylation at Ser-744 was determined using an antibody that detects the phosphorylated state of this residue. Our results indicate that G(q) is necessary but not sufficient to mediate LPA-induced PKD activation. In addition to G(q), LPA requires additional G-protein pathways to elicit a maximal response with G(i) playing a critical role in Galpha(12/13) KO cells. We conclude that LPA induces PKD activation through G(q), G(i), and G(12) and propose that PKD activation is a point of convergence in the action of multiple G-protein pathways.

Citing Articles

GPCR-Gα13 Involvement in Mitochondrial Function, Oxidative Stress, and Prostate Cancer.

Wu D, Casey P Int J Mol Sci. 2024; 25(13).

PMID: 39000269 PMC: 11241654. DOI: 10.3390/ijms25137162.


Statins inhibit protein kinase D (PKD) activation in intestinal cells and prevent PKD1-induced growth of murine enteroids.

Sinnett-Smith J, Torres-Marquez M, Chang J, Shimizu Y, Hao F, Martin M Am J Physiol Cell Physiol. 2023; 324(4):C807-C820.

PMID: 36779664 PMC: 10042602. DOI: 10.1152/ajpcell.00286.2022.


Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.

Zhang X, Connelly J, Chao Y, Wang Q Biomolecules. 2021; 11(3).

PMID: 33807058 PMC: 8005150. DOI: 10.3390/biom11030483.


Novel Small Molecule Inhibitors of Protein Kinase D Suppress NF-kappaB Activation and Attenuate the Severity of Rat Cerulein Pancreatitis.

Yuan J, Tan T, Geng M, Tan G, Chheda C, Pandol S Front Physiol. 2017; 8:1014.

PMID: 29270134 PMC: 5725929. DOI: 10.3389/fphys.2017.01014.


Protein kinase D signaling in cancer: A friend or foe?.

Roy A, Ye J, Deng F, Wang Q Biochim Biophys Acta Rev Cancer. 2017; 1868(1):283-294.

PMID: 28577984 PMC: 5548606. DOI: 10.1016/j.bbcan.2017.05.008.